AZD1222

Category

“Operation Warp Speed” Moves to Warp 2: AstraZeneca Begins Phase 3, Experts Skeptical as Trump Administration Prepares for November 1 Vaccine Delivery, and Speed-Up May Involve an EUA

Monday, AstraZeneca said it has begun Phase 3 trials of AZD1222, its COVID-19 vaccine candidate. This makes them the third firm to be in Phase 3 for the virus. As chronicled by CNN August 31 and updated September 1, the vaccine is developed with Oxford University and...

Heroes Step Up: UW Madison Physician the First to Sign up to Participate in AZD1222 Trial at UW Hospital

The University of Wisconsin-Madison (UW Madison) has been selected as one of the first test sites in the country for the large Phase 3 AZD1222 clinical trial, investigating AstraZeneca’s experimental vaccine originally developed by the University of Oxford. Led by...

The AstraZeneca Phase 3 COVID-19 Vaccine Study: Unprecedented Compression of Timeline of Est. Start Date to Est. Primary Completion Date

Is President Trump preparing to fast track the AstraZeneca COVID-19 vaccine known as AZD1222? According to a report in the Financial Times, this is exactly what is being contemplated as the administration would “bypass normal regulatory standards to fast-track”...

MedPharmics Selected by AstraZeneca for Phase 3 COVID-19 Vaccine Trial: First Site in New Mexico to Enroll Soon

MedPharmics LLC, based in Louisiana, has mobilized its Albuquerque, New Mexico trial site location to support a COVID-19 vaccine clinical trial sponsored by AstraZeneca and Oxford University. In fact, this will be the first such site in all of New Mexico to enroll...

Northwestern Medicine Launches Major COVID-19 Study Registry & Gears up for AZD1222 Clinical Trial

Northwestern Medicine has been selected by AstraZeneca for participation in the prominent AZD1222 Phase 3 COVID-19 vaccine trial. One of the most promising of vaccine candidates it was originally developed by University of Oxford.  Northwestern University, one of...

Pin It on Pinterest